Omeprazole-induced blood dyscrasia in a Clozapinetreated patient

Innovations in Clinical Neuroscience

Volumn 9, Issue 9, 2012, Pages 14-17

  Philipps, Robert J ^a   Demler, Tammie Lee ^b   Lee, Claudia ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b Buffalo Psychiatric Center   (United States)

Author keywords

Agranulocytosis; Blood dyscrasia; Clozapine; Drug induced; Neutropenia; Omeprazole; Proton pump inhibitors; Radiotherapy

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLONAZEPAM; CLOZAPINE; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OMEPRAZOLE; OXCARBAZEPINE; PROTON PUMP INHIBITOR; QUETIAPINE; SERTRALINE; VALPROIC ACID;

ADULT; AGRANULOCYTOSIS; ARTICLE; BLOOD DYSCRASIA; CANCER RADIOTHERAPY; CASE REPORT; DISEASE SEVERITY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INGUINAL LYMPH NODE; INSOMNIA; IRRITABILITY; LEUKOCYTE COUNT; LEUKOPENIA; LONG TERM CARE; LYMPH NODE DISSECTION; MANIA; MELANOMA; NEUTROPENIA; NEUTROPHIL COUNT; PARANOIA; PATIENT MONITORING; POSTMARKETING SURVEILLANCE; RISK ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SKIN SURGERY;

EID: 84869027509     PISSN: 21588333     EISSN: 21588341     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. IMS Health Report. Top 20 global therapeutic classes, 2010, total audited markets [online]. http://www.imshealth.com/portal/site /ims/menuitem. Accessed 2012 March 20.
2. IMS Health Report. Top 20 U.S. pharmaceutical products by dispensed prescriptions [online]. http://www.imshealth.com/portal/site /ims/menuitem. Accessed 2012 March 20.
3. Dury S, Nardi J, Gozalo C, et al. Agranulocytosis induced by proton pump inhibitors. J Clin Gastroenterol. 2012 Jan 10. [Epub ahead of print].
4. Gouraud A, Vochelle V, Descotes J, Vial T. Proton pump inhibitorinduced neutropenia: possible crossreactivity between omeprazole and pantoprazole. Clin Drug Investig. 2010;30(8):559-563.
5. Holt TL, Coombes ID, Pillans PI, Scott IA. Neutropenia associated with omeprazole. Med J Australia. 1999; 170(3):141-142.
6. Ottervanger JP, Stricker BHC, Kappelle JW, Claas FHJ. Omeprazole-associated agranulocytosis. Eur J Haematol. 1995; 54(4):279-280.
7. Gabutti L, Stoller R, Vogt B. Omeprazole-induced agranulocytosis in a kidney transplant recipient. Nephrology Dialysis Transplantation. 1999;14(2):523-524.
8. Prilosec (omeprazole) package insert. Wilmington, DE: AstraZeneca; 2011 May.
9. Protonix (pantoprazole) package insert. Philadelphia, PA: Wyeth Laboratories; 2011 Oct.
10. Nexium (esomeprazole) injection package insert. Wilmington, DE: AstraZeneca; 2012 Jan.
11. Prevacid (lansoprazole) package insert. Deerfield, IL: Takeda Pharmaceuticals America, Inc.; 2011 Oct.
12. Aciphex (rabeprazole) package insert. Woodcliff Lake, NJ: Eisai Inc.; 2011 May.
13. Clozaril (clozapine) package insert. East Hanover, NJ: Novartis Pharmaceuticals Corporation; 2011 Oct.
14. Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol Clin Exp. 2008;23:27-41.
15. Opgen-Rhein C, Dettling M. Clozapine-induced agranulocytosis and its genetic determinants. Pharmacogenomics. 2008;9(8):1101-1111.
16. Alvir JMJ, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis: Incidence and risk factors in the united states. N Engl J Med. 1993;329:162-167.
17. Andres E, Maloisel F. Idiosyncratic drug-induced agranulocytosis or acute neutropenia. Curr Opin Hematol. 2008;15(1):15-21.
18. Tesfa D, Keisu M, Palmblad J. Idiosyncratic drug-induced agranulocytosis: Possible mechanisms and management. Am J Hematol. 2009;84:428-434.
19. Andres E, Zimmer J, Mecili M, et al. Clinical presentation and management of drug-induced agranulocytosis. Exp Rev Hematol. 2011;4(2):143-151.
20. Andres E, Zimmer J, Affenberger S, et al. Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. Eur J Intern Med. 2006;17(8):529-535.
21. Andres E, Federici L, Weitten T, et al. Recognition and management of drug-induced blood cytopenias: The example of drug-induced acute neutropenia and agranulocytosis. Exp Opin Drug Safe. 2008;7(4):481-489.
22. Weiss JF, Landauer MR. History and development of radiation-protective agents. International J Radiation Biol. 2009;85(7):539-573.
23. Marks LB, Friedman HS, Kurtzberg J, et al. Reversal of radiationinduced neutropenia by granulocyte colony-stimulating factor. Med Pediatr Oncol. 1992;20(3):240-242.
24. Whiskey E, Taylor D. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities. CNS Drugs. 2007;21(1):25-35.